Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14393)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Little R, Wine E, Kamath BM, Griffiths AM, Ricciuto A. Gut microbiome in primary sclerosing cholangitis: A review. World J Gastroenterol 2020; 26(21): 2768-2780 [PMID: 32550753 DOI: 10.3748/wjg.v26.i21.2768] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v26/i21/2768.htm |
| Number | Citing Articles |
| 1 |
Henry H. Nguyen, Marvin J. Fritzler, Mark G. Swain. A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes. Frontiers in Molecular Medicine 2022; 2 doi: 10.3389/fmmed.2022.914505
|
| 2 |
Federica Giambò, Chiara Costa, Michele Teodoro, Concettina Fenga. Role-Playing Between Environmental Pollutants and Human Gut Microbiota: A Complex Bidirectional Interaction. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.810397
|
| 3 |
Yongfei He, Tianyi Liang, Zijun Chen, Shutian Mo, Yuan Liao, Qiang Gao, Ketuan Huang, Tao Peng, Weijie Zhou, Chuangye Han, Md Sayed Ali Sheikh. Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/7261786
|
| 4 |
Valeria Maccauro, Francesca Fianchi, Antonio Gasbarrini, Francesca Romana Ponziani. Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications. Digestive Diseases 2024; : 1 doi: 10.1159/000538493
|
| 5 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Luigi Boccuto, Emidio Scarpellini, Nazarii Kobyliak, Ludovico Abenavoli. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina 2022; 58(1): 84 doi: 10.3390/medicina58010084
|
| 6 |
Robert N. Lopez, Steven T. Leach, Nerissa Bowcock, Elise Coker, Amanda J. Shapiro, Andrew S. Day, Daniel A. Lemberg. Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study. Pathogens 2023; 12(4): 585 doi: 10.3390/pathogens12040585
|
| 7 |
Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy. The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications. International Journal of Molecular Sciences 2023; 24(5): 4841 doi: 10.3390/ijms24054841
|
| 8 |
Tianhao Zhou, AbdiGhani Ismail, Heather Francis. Bile Acids in Autoimmune Liver Disease: Unveiling the Nexus of Inflammation, Inflammatory Cells, and Treatment Strategies. Cells 2023; 12(23): 2725 doi: 10.3390/cells12232725
|
| 9 |
Dong Wu, Dan Chen, Wen Shi, Wei Liu, Weixun Zhou, Jiaming Qian, Yu-Chen Fan. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9936932
|
| 10 |
Xi-Mei Xue, Chan Xiong, Masafumi Yoshinaga, Barry Rosen, Yong-Guan Zhu. The enigma of environmental organoarsenicals: Insights and implications. Critical Reviews in Environmental Science and Technology 2022; 52(21): 3835 doi: 10.1080/10643389.2021.1947678
|
| 11 |
Francesco Nappi. Current Knowledge of Enterococcal Endocarditis: A Disease Lurking in Plain Sight of Health Providers. Pathogens 2024; 13(3): 235 doi: 10.3390/pathogens13030235
|
| 12 |
A Current Understanding of Bile Acids in Chronic Liver Disease. Journal of Clinical and Experimental Hepatology 2022; 12(1): 155 doi: 10.1016/j.jceh.2021.08.017
|
| 13 |
Cyriac Abby Philips, Philip Augustine. Review: Microbial Therapeutics for Liver Disease. Journal of Gastrointestinal Infections 2023; 13(01): 001 doi: 10.1055/s-0043-1768145
|
| 14 |
Lu Jiang, Peter Stärkel, Jian-Gao Fan, Derrick Eugene Fouts, Petra Bacher, Bernd Schnabl. The gut mycobiome: a novel player in chronic liver diseases. Journal of Gastroenterology 2021; 56(1): 1 doi: 10.1007/s00535-020-01740-5
|
| 15 |
Harry Sutton, Saul J. Karpen, Binita M. Kamath. Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms. Annual Review of Pathology: Mechanisms of Disease 2024; 19(1): 319 doi: 10.1146/annurev-pathmechdis-031521-025623
|
| 16 |
Andreas Blesl, Vanessa Stadlbauer. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021; 13(3): 1018 doi: 10.3390/nu13031018
|
| 17 |
Samaneh Ostadmohammadi, Masoumeh Azimirad, Hamidreza Houri, Kaveh Naseri, Ehsan Javanmard, Hamed Mirjalali, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls. Molecular Biology Reports 2021; 48(7): 5519 doi: 10.1007/s11033-021-06567-8
|
| 18 |
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; : 129 doi: 10.1007/978-3-031-14744-9_11
|
| 19 |
Benjamin Hart, Jasmin Patel, Pieter De Maayer, Ekene Emmanuel Nweke, Damon Bizos. Metataxonomic Analysis Demonstrates a Shift in Duodenal Microbiota in Patients with Obstructive Jaundice. Microorganisms 2023; 11(6): 1611 doi: 10.3390/microorganisms11061611
|
| 20 |
Amanda Ricciuto, Kuan Liu, Wael El‐Matary, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Matthew D. Di Guglielmo, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Katryn N. Furuya, Nitika Gupta, Stephen Guthery, Simon P. Horslen, Kyle Jensen, Binita M. Kamath, Nanda Kerkar, B. G. P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Cara Mack, Mercedes Martinez, Aldo Montano‐Loza, Nadia Ovchinsky, Alexandra Papadopoulou, Emily R. Perito, Pushpa Sathya, Kathleen B. Schwarz, Uzma Shah, Eyal Shteyer, Nisreen Soufi, James Patrick Stevens, Amy Taylor, M. Elizabeth Tessier, Pamela Valentino, Marek Woynarowski, Mark Deneau. Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium. Alimentary Pharmacology & Therapeutics 2024; 59(10): 1236 doi: 10.1111/apt.17936
|
| 21 |
Sofia Tejada, Raquel Martinez-Reviejo, Taísa A. Nogueira, Aroa Gómez, Teresa Pont, Xuelian Liao, Zheng Zhang, Oriol Manuel, Jordi Rello. The effect of sex inequality on solid organ transplantation: A systematic review and meta-analysis. European Journal of Internal Medicine 2023; 109: 58 doi: 10.1016/j.ejim.2022.12.009
|
| 22 |
Taqwa Ahmed, Maia Kayal, Dana Hashem, Ryan C. Ungaro. Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 2023; 68(4): 1118 doi: 10.1007/s10620-023-07826-3
|
| 23 |
Shengmin Yan, Xiao-Ming Yin. Gut microbiome in liver pathophysiology and cholestatic liver disease. Liver Research 2021; 5(3): 151 doi: 10.1016/j.livres.2021.08.001
|
| 24 |
Lie Zheng. New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(30): 10823-10839 doi: 10.12998/wjcc.v10.i30.10823
|
| 25 |
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Nazarii Kobyliak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 275 doi: 10.1007/978-3-031-19564-8_10
|
| 26 |
Songhee Lee, Heesang You, Minho Lee, Doojin Kim, Sunghee Jung, Youngsook Park, Sunghee Hyun. Different Reactions in Each Enterotype Depending on the Intake of Probiotic Yogurt Powder. Microorganisms 2021; 9(6): 1277 doi: 10.3390/microorganisms9061277
|
| 27 |
Changyan Zi, Die Wang, Yongxiang Gao, Lisha He. The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1104943
|
| 28 |
Angelo Di Giorgio, Diego Vergani, Giorgina Mieli-Vergani. Cutting edge issues in juvenile sclerosing cholangitis. Digestive and Liver Disease 2022; 54(4): 417 doi: 10.1016/j.dld.2021.06.028
|
| 29 |
Kristofer Andréasson, S. Melanie Lee, Venu Lagishetty, Meifang Wu, Natalie Howlett, Roger Hesselstrand, Philip J. Clements, Jonathan P. Jacobs, Elizabeth R. Volkmann. Disease Features and Gastrointestinal Microbial Composition in Systemic Sclerosis Patients from Two Independent Cohorts. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3893548
|
| 30 |
Mireya Viviana Belloso Daza, Ana C. Almeida-Santos, Carla Novais, Antónia Read, Valquíria Alves, Pier Sandro Cocconcelli, Ana R. Freitas, Luísa Peixe, Jose A. Lemos.
Distinction between Enterococcus faecium and Enterococcus lactis by a
gluP
PCR-Based Assay for Accurate Identification and Diagnostics
. Microbiology Spectrum 2022; 10(6) doi: 10.1128/spectrum.03268-22
|
| 31 |
Manon Karemera, Marko Verce, Martin Roumain, Giulio G. Muccioli, Patrice D. Cani, Amandine Everard, Xavier Stephenne, Etienne Sokal. Pediatric Autoimmune or Primary Sclerosing Cholangitis: Metronidazole Effectiveness on Biochemical Data, Bile Acid Profile, and Gut Microbiota: A Pilot Study. JPGN Reports 2023; 4(3): e334 doi: 10.1097/PG9.0000000000000334
|
| 32 |
Xiru Liang, Ziwei Wang, Qiuai Shu, Xindi Huang, Jinhai Wang, Jian Wu, Na Liu, Ning Xie. A bidirectional two-sample Mendelian randomization using the gut microbiota to reveal potential therapeutic targets for primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2024; 36(2): 147 doi: 10.1097/MEG.0000000000002666
|
| 33 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 34 |
Yizhe Tie, Yongle Huang, Rirong Chen, Li Li, Minhu Chen, Shenghong Zhang. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2265028
|
| 35 |
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?. Journal of Hepatology 2024; 80(1): 155 doi: 10.1016/j.jhep.2023.09.031
|
| 36 |
Jing Liu, Dakai Yang, Xiaojing Wang, Paul Tetteh Asare, Qingwen Zhang, Lixin Na, Lei Shao. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.774335
|
| 37 |
Ruslan A. Mammadov, Jasmijn W. Selten, Henk P. Roest, Cornelia J. Verhoeven, Luca Maroni, Sandra I. Bril, Dagmar Tolenaars, Pravesh S. Gadjradj, Stan F.J. van de Graaf, Ronald P.J. Oude Elferink, Jaap Kwekkeboom, Herold J. Metselaar, Maikel P. Peppelenbosch, Ulrich Beuers, Jan N.M. IJzermans, Luc J.W. van der Laan. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis. Transplantation 2023; 107(8): 1764 doi: 10.1097/TP.0000000000004563
|
| 38 |
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
|
| 39 |
Kristofer Andréasson, S. Melanie Lee, Venu Lagishetty, Meifang Wu, Natalie Howlett, James English, Roger Hesselstrand, Philip J. Clements, Jonathan P. Jacobs, Elizabeth R. Volkmann. Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts. ACR Open Rheumatology 2022; 4(5): 417 doi: 10.1002/acr2.11387
|
| 40 |
Luisa Denoth, Pascal Juillerat, Andreas E. Kremer, Gerhard Rogler, Michael Scharl, Bahtiyar Yilmaz, Sena Bluemel. Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis. Microorganisms 2021; 9(8): 1752 doi: 10.3390/microorganisms9081752
|
| 41 |
Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. International Journal of Molecular Sciences 2021; 22(15): 8309 doi: 10.3390/ijms22158309
|
| 42 |
Nicholas E. Ilott, Mastura Neyazi, Carolina V. Arancibia-Cárcamo, Fiona Powrie, Alessandra Geremia. Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease. Wellcome Open Research 2022; 6: 199 doi: 10.12688/wellcomeopenres.16901.2
|
| 43 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9): 2660-2677 doi: 10.12998/wjcc.v10.i9.2660
|
| 44 |
Sasha R. Fehily, Chamara Basnayake, Emily K. Wright, Michael A. Kamm. The gut microbiota and gut disease. Internal Medicine Journal 2021; 51(10): 1594 doi: 10.1111/imj.15520
|
| 45 |
Gisa Tiegs, Andrea K. Horst. TNF in the liver: targeting a central player in inflammation. Seminars in Immunopathology 2022; 44(4): 445 doi: 10.1007/s00281-022-00910-2
|
| 46 |
Benedikt Hild, Hauke S. Heinzow, Hartmut H. Schmidt, Miriam Maschmeier. Bile Acids in Control of the Gut-Liver-Axis. Zeitschrift für Gastroenterologie 2021; 59(01): 63 doi: 10.1055/a-1330-9644
|
| 47 |
Paola Di Carlo, Nicola Serra, Rosa Alduina, Riccardo Guarino, Antonio Craxì, Anna Giammanco, Teresa Fasciana, Antonio Cascio, Consolato M. Sergi. A systematic review on omics data (metagenomics, metatranscriptomics, and metabolomics) in the role of microbiome in gallbladder disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.888233
|
| 48 |
Shengmin Yan, Bilon Khambu, Xiaoyun Chen, Zheng Dong, Grace Guo, Xiao-Ming Yin. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(4): 973 doi: 10.1016/j.jcmgh.2020.10.011
|
| 49 |
Nicholas E. Ilott, Mastura Neyazi, Carolina V. Arancibia-Cárcamo, Fiona Powrie, Alessandra Geremia. Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease. Wellcome Open Research 2021; 6: 199 doi: 10.12688/wellcomeopenres.16901.1
|
| 50 |
Jiale Wang, Xiaoting Zhu, Yuhui Li, Wenping Guo, Mingquan Li, Weidong Pan. Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/4023006
|
| 51 |
James P. Stevens, Nitika A. Gupta. Recent Insights into Pediatric Primary Sclerosing Cholangitis. Clinics in Liver Disease 2022; 26(3): 489 doi: 10.1016/j.cld.2022.03.009
|
| 52 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 53 |
Qiwei QIAN, Wei HE, Ruqi TANG, Xiong MA. Implications of gut microbiota in autoimmune liver diseases. Minerva Gastroenterology 2023; 69(1) doi: 10.23736/S2724-5985.21.02860-9
|
| 54 |
Aalam Sohal, Kris V. Kowdley. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape. Expert Opinion on Investigational Drugs 2024; 33(4): 335 doi: 10.1080/13543784.2024.2330738
|
| 55 |
Cheng Ye, Chunlu Dong, Yanyan Lin, Huaqing Shi, Wence Zhou. Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and Therapy. Microorganisms 2023; 11(10): 2598 doi: 10.3390/microorganisms11102598
|
| 56 |
Katy L. Lawson, Hanlin L. Wang. Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic Cholangiopathy. Surgical Pathology Clinics 2023; 16(3): 533 doi: 10.1016/j.path.2023.04.008
|
| 57 |
Aaron M. T. Barnes, Kristi L. Frank, Gary M. Dunny. Enterococcal Endocarditis: Hiding in Plain Sight. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.722482
|
| 58 |
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021; 9(2): 53 doi: 10.1080/21678707.2021.1898370
|
| 59 |
Ze Xiang, Jian Wu, Jiarui Li, Shusen Zheng, Xuyong Wei, Xiao Xu. Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation. Engineering 2023; 29: 59 doi: 10.1016/j.eng.2022.12.012
|
| 60 |
K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu. The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics. Advanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/5431615
|
| 61 |
Robert van Vorstenbosch, Kim van Munster, Danielle Pachen, Alex Mommers, Georgios Stavropoulos, Frederik-Jan van Schooten, Cyriel Ponsioen, Agnieszka Smolinska. The Detection of Primary Sclerosing Cholangitis Using Volatile Metabolites in Fecal Headspace and Exhaled Breath. Metabolites 2023; 14(1): 23 doi: 10.3390/metabo14010023
|
| 62 |
Fiorella D’Onofrio, Giorgia Renga, Matteo Puccetti, Marilena Pariano, Marina Maria Bellet, Ilaria Santarelli, Claudia Stincardini, Paolo Mosci, Maurizio Ricci, Stefano Giovagnoli, Claudio Costantini, Luigina Romani. Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis. Cells 2021; 10(7): 1622 doi: 10.3390/cells10071622
|
| 63 |
Kertu Liis Krigul, Oliver Aasmets, Kreete Lüll, Tõnis Org, Elin Org. Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99046-w
|
| 64 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9): 2658 doi: 10.12998/wjcc.v10.i9.2658
|
| 65 |
Shih-Cheng Chang, Shu-Fu Lin, Szu-Tah Chen, Pi-Yueh Chang, Yuan-Ming Yeh, Fu-Sung Lo, Jang-Jih Lu. Alterations of Gut Microbiota in Patients With Graves’ Disease. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.663131
|
| 66 |
Cynthia L. Hsu, Yi Duan, Derrick E. Fouts, Bernd Schnabl. Intestinal virome and therapeutic potential of bacteriophages in liver disease. Journal of Hepatology 2021; 75(6): 1465 doi: 10.1016/j.jhep.2021.08.003
|
| 67 |
Li Wang, Zheng-Min Cao, Li-Li Zhang, Juan-mei Li, Wen-liang Lv. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.923599
|
| 68 |
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196
|
| 69 |
Jennifer Christine Halma, Laura Cristoferi, Marco Carbone. The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2023; 21(10): 2699 doi: 10.1016/j.cgh.2022.11.017
|
| 70 |
Xinhe Zhang, Xuyong Lin, Xuedan Li, Lin Guan, Yiling Li, Ningning Wang. Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1132072
|
| 71 |
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022; 10(6): 1288 doi: 10.3390/biomedicines10061288
|
| 72 |
Qianfei Zhang, Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P. Diggs, Lichun Ma, Soumen Roy, Qiong Fu, Zachary J. Brown, Simon Wabitsch, Vishal Thovarai, Jianyang Fu, Dechun Feng, Benjamin Ruf, Linda L. Cui, Varun Subramanyam, Karen M. Frank, Sophie Wang, David E. Kleiner, Thomas Ritz, Christian Rupp, Bin Gao, Thomas Longerich, Alexander Kroemer, Xin Wei Wang, Mathuros Ruchirawat, Firouzeh Korangy, Bernd Schnabl, Giorgio Trinchieri, Tim F. Greten. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma. Cancer Discovery 2021; 11(5): 1248 doi: 10.1158/2159-8290.CD-20-0304
|
| 73 |
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. International Journal of Molecular Sciences 2021; 22(13): 6975 doi: 10.3390/ijms22136975
|